Cargando…
Few new drugs deserve expedited regulatory treatment
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390900/ https://www.ncbi.nlm.nih.gov/pubmed/33908278 http://dx.doi.org/10.18553/jmcp.2021.27.5.685 |
| _version_ | 1785082578721570816 |
|---|---|
| author | Darrow, Jonathan J |
| author_facet | Darrow, Jonathan J |
| author_sort | Darrow, Jonathan J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10390900 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103909002023-08-02 Few new drugs deserve expedited regulatory treatment Darrow, Jonathan J J Manag Care Spec Pharm Perspectives on Expedited FDA Approval Academy of Managed Care Pharmacy 2021-05 /pmc/articles/PMC10390900/ /pubmed/33908278 http://dx.doi.org/10.18553/jmcp.2021.27.5.685 Text en Copyright © 2021, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Perspectives on Expedited FDA Approval Darrow, Jonathan J Few new drugs deserve expedited regulatory treatment |
| title | Few new drugs deserve expedited regulatory treatment |
| title_full | Few new drugs deserve expedited regulatory treatment |
| title_fullStr | Few new drugs deserve expedited regulatory treatment |
| title_full_unstemmed | Few new drugs deserve expedited regulatory treatment |
| title_short | Few new drugs deserve expedited regulatory treatment |
| title_sort | few new drugs deserve expedited regulatory treatment |
| topic | Perspectives on Expedited FDA Approval |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390900/ https://www.ncbi.nlm.nih.gov/pubmed/33908278 http://dx.doi.org/10.18553/jmcp.2021.27.5.685 |
| work_keys_str_mv | AT darrowjonathanj fewnewdrugsdeserveexpeditedregulatorytreatment |